Ghrelin promotes conditioning to food-related odours
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty food smells, encouraging overeating and obesity. New research on the hormone ghrelin was published on Dec. 4, 2018, led by Dr. Alain Dagher’s lab at the Montreal Neurological Institute and Hospital of McGill University.
Using functional magnetic resonance imaging (fMRI), the researchers recorded activity in brain regions known to be involved in reward response from dopamine. They found that activity in these regions was higher in subjects injected with ghrelin, but only when responding to the images associated with food smells. This means that ghrelin is controlling the extent to which the brain associates reward with food odours.
Subjects also rated the pleasantness of the images associated with food odour, and the results showed that ghrelin both reduced the response time and increased the perceived pleasantness of food-associated images, but had no effect on their reaction to images associated with non-food odours.
People struggling with obesity often have abnormal reactivity to the food-related cues that are abundant in our environment, for example fast food advertising. This study shows that ghrelin may be a major factor in their heightened response to food cues. The brain regions identified have been linked to a neural endophenotype that confers vulnerability to obesity, suggesting a genetically-based hypersensitivity to food-associated images and smells.
“Obesity is becoming more common around the world and it’s well known to cause health problems such as heart disease and diabetes,” says Dr. Dagher. “This study describes the mechanism through which ghrelin makes people more vulnerable to hunger-causing stimuli, and the more we know about this, the easier it will be to develop therapies that counteract this effect.”
This study was published open access in Cell Reports, and was made possible with funding from the Canadian Institutes of Health Research.
The Montreal Neurological Institute and Hospital – The Neuro – is a world-leading destination for brain research and advanced patient care. Since its founding in 1934 by renowned neurosurgeon Dr. Wilder Penfield, The Neuro has grown to be the largest specialized neuroscience research and clinical center in Canada, and one of the largest in the world. The seamless integration of research, patient care, and training of the world’s top minds make The Neuro uniquely positioned to have a significant impact on the understanding and treatment of nervous system disorders. The Montreal Neurological Institute is a McGill University research and teaching institute. The Montreal Neurological Hospital is part of the Neuroscience Mission of the McGill University Health Centre. For more information, please visit www.theneuro.ca